Antibodies that recognize the SARS-CoV-2 spike protein show potential for diagnosing COVID-19.
Just because a molecular target resides inside a cancer cell does not mean that it cannot be targeted by antibodies, says Qi Zeng, founder of A*STAR spin-off company Intra-ImmuSG.
An antibody that targets a protein on the surface of stem cells also targets the same protein on some cancer cells
A protein produced by cells in response to stress can improve the production of biological medicines
A tool for isolating progenitor cells from human heart tissue could pave the way for cardiac cell therapy
Self-cleaving peptides are key for easy and efficient monoclonal antibody production
Magnetic nanoparticles break the capacity barrier for antibody purification